Stifel Nicolaus analyst Benjamin Burnett maintained a Buy rating on Revolution Medicines (RVMD – Research Report) on November 8 and set a ...

Warning! GuruFocus has detected 6 Warning Signs with RVMD. Revolution Medicines Inc (NASDAQ:RVMD), a clinical-stage precision ...

On Friday, Revolution Medicines Inc (RVMD) stock saw a modest uptick, ending the day at $60.44 which represents a slight increase of $1.34 or 2.27% from the prior close of $59.1. The stock opened at ...

Revolution Medicines (NASDAQ:RVMD – Free Report) had its target price increased by Needham & Company LLC from $61.00 to $68.00 in a report issued on Thursday morning,Benzinga reports. They currently ...

In a report released on November 7, Jonathan Chang from Leerink Partners reiterated a Buy rating on Revolution Medicines (RVMD – Research ...

Revolution Medicines, Inc. (NASDAQ: RVMD) Q3 2024 Earnings Call Transcript November 6, 2024 Revolution Medicines, Inc. misses on earnings expectations. Reported EPS is $-0.94 EPS, expectations were ...

December S&P 500 E-Mini futures (ESZ24) are trending up +2.24% this morning after Republican Donald Trump won the U.S. presidential election. Donald Trump was elected the 47th president of the United ...

SEC Filings provided by EDGAR Online, Inc.

Featured here, the Income Statement (earnings report) for Revolution Medicines Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses ...

2-Year U.S. Treasury Note Continuous Contract $102.668 0.070 0.07% 5-Year U.S. Treasury Note Continuous Contract $106.609 0.109 0.10% 10-Year U.S. Treasury Note Continuous Contract $109.516 0.094 ...